ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

Cell-based and 3D models at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

93 organizations at ELRIG Drug Discovery 2026 present work in cell-based and 3D models: 80 technology and service providers, 9 academic, government and non-profit bodies and 4 drug developers. Between them they bring 37 presentations to the program. Most represented: GSK (8 on the program), LifeArc (2 on the program), University of Oxford (2 on the program). As of Oct 8, 2026.

All 388 organizations at ELRIG Drug Discovery 2026 →

Showing 1–14 of 93 organizations

Organization	ELRIG Drug Discovery 2026 Attendance
GSK London, UK	◆Partner
gsk.com Large pharmaPartner Global biopharmaceutical company developing vaccines and specialty medicines in infectious disease, HIV, respiratory, immunology and oncology.	Booth Exhibiting at Booth CZ02 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Engineering the cell microenvironment: Cell-based models for drug discovery How engineered cell surroundings, from three-dimensional cultures to immune-competent models, help lab assays better predict what happens in patients. Auditorium 1 with Nottingham Trent University Talk Wed Oct 14 11:20am–11:50am Biophysics: A Look Back at Changing Tools and Changing Questions Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:00pm–2:30pm Designing Smarter Experiments: Connecting DoE, Laboratory Automation and AI in a Translational Discovery Workflow Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 2:00pm–2:30pm Sarcoma patient derived 3D cell culture models for drug discovery and prediction of the clinical trials outcome Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 2:40pm–3:10pm Patient-Derived Intestinal Organoids: Advancing Gut Complexity for Drug Discovery and Development Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Wed Oct 14 5:30pm–6:30pm Early Career Professionals: Network Like A Boss Meeting other early career professionals in speed networking rounds to build the contacts a drug discovery career depends on. Learning Zone with Liverpool School of Tropical Medicine Panel Thu Oct 15 9:30am–10:15am Keynote Panel - 20 Years of Discovery: Lessons from the Past, Blueprints for the Next 20 What two decades of change in drug discovery, from high-throughput screening to AI design, teach about building the next generation of medicines. Auditorium 1 with Constructive Bio, Omega Funds, OtoImmune +1 more Talk Thu Oct 15 2:30pm–3:00pm Automated Molecular Design in BRADSHAW: Application to GSK Projects Auditorium 3 AI in medicinal chemistry
LifeArc London, UK	◆Partner
lifearc.org Gov/NGOPartner UK medical research charity that funds and runs translational research and drug discovery to move science toward patients.	Booth Exhibiting at Booth CZ03 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 9:20am–9:25am Conference Director Welcome & Keynote Introduction Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery · with Black Medical and Scientific Network, Novo Nordisk, Novartis Talk Wed Oct 14 9:25am–10:10am Plenary Keynote - Where Need Meets Momentum: The Next 20 Years Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery
University of Oxford Oxford, UK
ox.ac.uk Academic & healthcare Collegiate research university in Oxford.	Talk Wed Oct 14 3:45pm–4:15pm Decoding how immune receptors and extracellular vesicles build lymphocyte networks using synthetic cells, lymphoid organoids, and tumoroids Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery Talk Thu Oct 15 11:55am–12:25pm From Mechanism to Evidence: Cardiovascular Imaging Biomarkers and Surrogate Endpoints in Drug Development Auditorium 2 The power of imaging in drug discovery and the clinic
Axxam Milan, Italy	◆Conference Partner
axxam.com CROs & CDMOsConference Partner Contract research organisation offering integrated early discovery, from AI-supported target identification and validation through hit finding to hit-to-lead, with compound collections.	Booth Exhibiting at Booth G06, G07 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Thu Oct 15 11:25am–11:55am From Gene Perturbation to Phenotype: Integrating Cell Painting and Transcriptomics in Human iPSC-Derived Motor Neurons Auditorium 2 The power of imaging in drug discovery and the clinic
BM Black Medical and Scientific Network	◆Partner
Gov/NGOPartner UK membership network, founded in 2020, supporting Black and minority-ethnic students and professionals in science and medicine.	Booth Exhibiting at Booth K30 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 9:20am–9:25am Conference Director Welcome & Keynote Introduction Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery · with LifeArc, Novo Nordisk, Novartis
Lonza Basel, Switzerland
lonza.com Reagents, assays & models Swiss life science group; its Bioscience unit supplies cell culture and discovery tools, quality control tests and biomanufacturing software.	Booth Exhibiting at Booth J25 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 12:20pm–12:50pm Lonza’s GlycoConnect® Technology for Best-in-Class ADCs: Emerging Clinical Insights Auditorium 3 Targeted potency: Advances in radioligands and bioconjugates
CNPEM Campinas, Brazil
cnpem.br Academic & healthcare Brazil's national research center for energy and materials, running open-access facilities including automated high-throughput and high-content screening for drug discovery.	Talk Wed Oct 14 11:20am–11:50am Biodiversity at Scale Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery
ELRIG Cambridge, UK
elrig.org Gov/NGO Not-for-profit organisation running free-to-attend scientific meetings for life science and drug discovery researchers; organiser of this meeting.	Talk Wed Oct 14 9:00am–9:20am ELRIG Welcome - 20 years of community and inclusion Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery
Nottingham Trent University Nottingham, UK
	Chair Wed Oct 14 11:15am–11:20am Track Chair - Engineering the cell microenvironment: Cell-based models for drug discovery How engineered cell surroundings, from three-dimensional cultures to immune-competent models, help lab assays better predict what happens in patients. Auditorium 1 with GSK
Novartis Basel, Switzerland
novartis.com Large pharma Global pharmaceutical company developing innovative medicines across major therapeutic areas.	Chair Wed Oct 14 9:20am–9:25am Conference Director Welcome & Keynote Introduction Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery · with Black Medical and Scientific Network, LifeArc, Novo Nordisk
Novo Nordisk Bagsværd, Denmark
novonordisk.com Large pharma Global pharmaceutical company focused on diabetes, obesity and other serious chronic diseases.	Chair Wed Oct 14 9:20am–9:25am Conference Director Welcome & Keynote Introduction Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery · with Black Medical and Scientific Network, LifeArc, Novartis
Swansea University Swansea, UK
swansea.ac.uk Academic & healthcare Public research university in Swansea, Wales.	Talk Wed Oct 14 12:20pm–12:50pm Novel Therapeutic Targets in Cancer: Translating RAGE and Calpain Biology into Therapeutics, Biomarkers, and Patient Benefit Auditorium 1 Engineering the cell microenvironment: Cell-based models for drug discovery
Evotec Hamburg, Germany
evotec.com CROs & CDMOs Drug discovery and development partner offering CRO and CDMO services, integrated programs and strategic partnerships from target to clinic.	Booth Exhibiting at Booth C33 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 12:05pm–12:20pm A Transcriptomics‑AI Framework for Early Detection and De‑Risking of Nephrotoxicity How gene activity readouts combined with machine learning flagged kidney-damaging compounds early and pointed to the mechanisms behind the injury. Auditorium 1 Talk Wed Oct 14 4:15pm–4:30pm Biosensor based screening of large lead like chemical libraries in pools - an alternative biophysical approach for hit identification in small molecule drug discovery Screening large pools of lead-like compounds with surface plasmon resonance and related biosensors to find direct binders and measure their binding behaviour. Auditorium 4
AA Anivance AI
CROs & CDMOs Generates human-relevant evidence for drug development by combining tissue models, organ-on-chip systems, real-time sensing, automation and AI analysis.	Booth Exhibiting at Booth K25 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 2:35pm–2:40pm Technology Spotlight Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery